Total Payments
$2,993
2024 Payments
$796.11
Companies
33
Transactions
165
Medicare Patients
1,226
Medicare Billing
$307,872
Payment Breakdown by Category
Food & Beverage$2,993 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,993 | 165 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $497.12 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $361.74 | 19 | $0 (2024) |
| PFIZER INC. | $297.33 | 19 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $219.33 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $189.70 | 10 | $0 (2021) |
| ABBVIE INC. | $181.28 | 10 | $0 (2022) |
| Merck Sharp & Dohme LLC | $166.25 | 10 | $0 (2022) |
| Novo Nordisk Inc | $140.77 | 7 | $0 (2024) |
| Lilly USA, LLC | $113.76 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $93.55 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $796.11 | 39 | AstraZeneca Pharmaceuticals LP ($188.16) |
| 2023 | $381.04 | 18 | AstraZeneca Pharmaceuticals LP ($96.28) |
| 2022 | $380.45 | 18 | Merck Sharp & Dohme LLC ($61.40) |
| 2021 | $433.13 | 26 | AbbVie Inc. ($120.51) |
| 2020 | $109.47 | 7 | Allergan, Inc. ($30.93) |
| 2019 | $190.79 | 11 | Novartis Pharmaceuticals Corporation ($57.08) |
| 2018 | $276.49 | 16 | Novartis Pharmaceuticals Corporation ($77.77) |
| 2017 | $425.14 | 30 | PFIZER INC. ($105.14) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.49 | General |
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Gastroenterology | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.23 | General |
| 08/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Gastroenterology | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Respiratory | ||||||
| 06/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 375 | 1,421 | $240,652 | $102,486 |
| 2022 | 3 | 280 | 1,107 | $186,450 | $76,991 |
| 2021 | 4 | 241 | 794 | $129,930 | $54,293 |
| 2020 | 6 | 330 | 1,165 | $172,770 | $74,102 |
Total Patients
1,226
Total Services
4,487
Medicare Billing
$307,872
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 157 | 1,031 | $144,340 | $67,924 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 264 | $46,200 | $18,931 | 41.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 105 | 108 | $48,600 | $15,461 | 31.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 18 | $1,512 | $169.34 | 11.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 97 | 721 | $100,940 | $43,342 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 310 | $51,310 | $20,949 | 40.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 71 | 76 | $34,200 | $12,700 | 37.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 53 | 392 | $54,880 | $24,096 | 43.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 127 | 335 | $50,870 | $21,116 | 41.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 47 | 52 | $22,920 | $8,909 | 38.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 15 | $1,260 | $172.38 | 13.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 80 | 681 | $95,340 | $42,519 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 155 | 378 | $49,140 | $19,026 | 38.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 57 | 67 | $26,070 | $11,644 | 44.7% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $480.00 | $480.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $480.00 | $227.52 | 47.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 15 | $1,260 | $205.95 | 16.3% |
About Dr. Munazza Khan, M.D
Dr. Munazza Khan, M.D is a Internal Medicine healthcare provider based in Costa Mesa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609897479.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Munazza Khan, M.D has received a total of $2,993 in payments from pharmaceutical and medical device companies, with $796.11 received in 2024. These payments were reported across 165 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,993).
As a Medicare-enrolled provider, Khan has provided services to 1,226 Medicare beneficiaries, totaling 4,487 services with total Medicare billing of $307,872. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Costa Mesa, CA
- Active Since 07/21/2006
- Last Updated 03/02/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609897479
Products in Payments
- TRELEGY ELLIPTA (Drug) $317.79
- XIFAXAN (Drug) $219.33
- ENTRESTO (Drug) $189.70
- FARXIGA (Drug) $171.03
- AIRSUPRA (Drug) $134.66
- BELSOMRA (Drug) $118.00
- ELIQUIS (Drug) $116.45
- UBRELVY (Drug) $102.89
- BREZTRI (Drug) $102.55
- VRAYLAR (Drug) $95.27
- Cologuard Collection Kit (Device) $86.74
- Otezla (Drug) $85.54
- CHANTIX (Drug) $81.42
- SYMBICORT (Drug) $73.07
- Dayvigo (Drug) $70.40
- JARDIANCE (Drug) $58.50
- Rybelsus (Drug) $49.28
- TRULICITY (Drug) $48.07
- PREMARIN (Drug) $46.70
- Ozempic (Drug) $45.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Costa Mesa
Dr. Hoan Le, Md, MD
Internal Medicine — Payments: $27,900
Internal Medicine $27,900
Alexander Sweidan, Md, MD
Internal Medicine — Payments: $10,223
Internal Medicine $10,223
Abdul Khan, M.d, M.D
Internal Medicine — Payments: $3,223
Internal Medicine $3,223
Dr. Shirin Afrasiabi, M.d. Inc, M.D. INC
Internal Medicine — Payments: $2,774
Internal Medicine $2,774
Roxanne Stallworth, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $2,567
Internal Medicine $2,567
Dr. Dariush Lavi, M.d, M.D
Internal Medicine — Payments: $2,306
Internal Medicine $2,306